Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05705674 · ClinicalTrials.gov registry record
The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
A clinical trial of Sanfilippo Syndrome and MPS3, sponsored by Lysosomal and Rare Disorders Research and Treatment Center.
- Recruiting
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT05705674: Recruiting study of Sanfilippo Syndrome and MPS3, sponsored by Lysosomal and Rare Disorders Research and Treatment Center.
NCT05705674 is a study of Sanfilippo Syndrome and MPS3 that is actively recruiting participants, run by Lysosomal and Rare Disorders Research and Treatment Center. The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05705674, a study of Sanfilippo Syndrome and MPS3, is actively recruiting participants, sponsored by Lysosomal and Rare Disorders Research and Treatment Center.
- RECRUITING
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The natural history study of patients with Sanfilippo disease(s) (MPS3)
Conditions Studied
Study Locations (1)
Virginia
- LDRTC - Fairfax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2024-12 |
What NCT05705674 shows while recruiting
NCT05705674 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 2 conditions, with Sanfilippo Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT05705674 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05705674 about?
NCT05705674 is a clinical study titled "The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)". The natural history study of patients with Sanfilippo disease(s) (MPS3)
What is the current status of trial NCT05705674?
This trial is currently recruiting. The enrollment target is 6 participants. The study started on 2023-05-01. Estimated completion is 2024-12.
What conditions does trial NCT05705674 study?
This clinical trial studies the following conditions: Sanfilippo Syndrome, MPS3.
Who is sponsoring clinical trial NCT05705674?
This trial is sponsored by Lysosomal and Rare Disorders Research and Treatment Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05705674 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sanfilippo Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI